Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer

1 Jun 2024

Abstract excerpt

Nitric oxide (NO) and reactive nitrogen species (RNS) exert profound biological impacts dictated by their chemistry. Understanding their spatial distribution is essential for deciphering their roles in diverse biological processes. This review establishes a framework for the chemical biology of NO and RNS, exploring their dynamic reactions within the context of cancer. Concentration-dependent signaling reveals...

Source

Identifiers

PMID: 38892290
DOI: 10.3390/ijms25116103

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast CancerPMID 38892290Read ↗

Understanding the tumour micro‐environment communication network from an NOS2/COX2 perspectiveSemantic proximity Read ↗

Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcomeSemantic proximity Read ↗

Elevated tumor NOS2/COX2 promotes immunosuppressive phenotypes associated with poor survival in ER– breast cancerSemantic proximity Read ↗

NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER-Breast CancerSemantic proximity Read ↗

Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patientsSemantic proximity Read ↗

The Role of Nitric Oxide in Cancer: Master Regulator or NOt?Semantic proximity Read ↗

The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 AxisSemantic proximity Read ↗

Unveiling the significance of inducible nitric oxide synthase: Its impact on cancer progression and clinical implicationsSemantic proximity Read ↗

The multifaceted roles of nitric oxide in cancerSemantic proximity Read ↗

Role of nitric oxide in tumour progression with special reference to a murine breast cancer modelSemantic proximity Read ↗

S-nitrosylated COX-2 is a microenvironment-regulated breast cancer cell biomarker of mesenchymal phenotypes.Semantic proximity Read ↗

Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.